Prognostic significance of intra-aortic balloon pumping support in patients with acute myocardial infarction and veno-arterial extracorporeal membrane oxygenation therapy.

[1]  A. Hirayama,et al.  Unmet needs for emergency care and prevention of prehospital death in acute myocardial infarction. , 2020, Journal of cardiology.

[2]  V. Figueredo,et al.  Mechanical Circulatory Support in Women. , 2020, Journal of cardiology.

[3]  Zhen Xing,et al.  Short-term outcomes of intra-aortic balloon pump combined with venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis. , 2019, Artificial organs.

[4]  B. Gersh,et al.  Concomitant Intra-Aortic Balloon Pump Use in Cardiogenic Shock Requiring Veno-Arterial Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis , 2018, Circulation. Cardiovascular interventions.

[5]  P. Leprince,et al.  Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[6]  James E. Tcheng,et al.  2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials , 2018, Circulation.

[7]  P. Demondion,et al.  Intra-aortic balloon pump protects against hydrostatic pulmonary oedema during peripheral venoarterial-extracorporeal membrane oxygenation , 2018, European heart journal. Acute cardiovascular care.

[8]  H. Yasunaga,et al.  The Effect of Intraaortic Balloon Pumping Under Venoarterial Extracorporeal Membrane Oxygenation on Mortality of Cardiogenic Patients: An Analysis Using a Nationwide Inpatient Database , 2016, Critical care medicine.

[9]  N. Chou,et al.  Effects of Additional Intra-aortic Balloon Counter-Pulsation Therapy to Cardiogenic Shock Patients Supported by Extra-corporeal Membranous Oxygenation , 2016, Scientific Reports.

[10]  J. Goldstein,et al.  2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation o , 2015, Journal of the American College of Cardiology.

[11]  D. Kolte,et al.  Peripheral Venoarterial Extracorporeal Membrane Oxygenation in Combination with Intra-Aortic Balloon Counterpulsation in Patients with Cardiovascular Compromise , 2014, Cardiology.

[12]  P. Leprince,et al.  Intra-Aortic Balloon Pump Effects on Macrocirculation and Microcirculation in Cardiogenic Shock Patients Supported by Venoarterial Extracorporeal Membrane Oxygenation* , 2014, Critical care medicine.

[13]  D. Brodie,et al.  Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. , 2014, Journal of the American College of Cardiology.

[14]  T. Park,et al.  Clinical impact of intra-aortic balloon pump during extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock , 2014, BMC Anesthesiology.

[15]  Xiaojing Ma,et al.  Combining ECMO with IABP for the treatment of critically Ill adult heart failure patients. , 2014, Heart, lung & circulation.

[16]  K. Soma,et al.  Therapeutic strategy using extracorporeal life support, including appropriate indication, management, limitation and timing of switch to ventricular assist device in patients with acute myocardial infarction , 2014, Journal of Artificial Organs.

[17]  Yeong-Hoon Choi,et al.  Outcomes after peripheral extracorporeal membrane oxygenation therapy for postcardiotomy cardiogenic shock: a single-center experience. , 2013, The Journal of surgical research.

[18]  G. Schuler,et al.  Intraaortic balloon support for myocardial infarction with cardiogenic shock. , 2012, The New England journal of medicine.

[19]  Kay-Hyun Park,et al.  Results of Extracorporeal Membrane Oxygenation (ECMO) Support before Coronary Reperfusion in Cardiogenic Shock with Acute Myocardial Infarction , 2011, The Korean Journal of Thoracic and Cardiovascular Surgery.

[20]  M. Hori,et al.  Impact of diabetes mellitus on rehospitalization for heart failure among survivors of acute myocardial infarction in the percutaneous coronary intervention era. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[21]  Pascal Leprince,et al.  Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock* , 2008, Critical care medicine.

[22]  Peter C Austin,et al.  The performance of different propensity score methods for estimating marginal hazard ratios , 2007, Statistics in medicine.

[23]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[24]  Adelaide,et al.  Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.

[25]  I. Komuro,et al.  Incidence, predictors, and subsequent mortality risk of recurrent myocardial infarction in patients following discharge for acute myocardial infarction. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[26]  I. Komuro,et al.  Oral treatment with nicorandil at discharge is associated with reduced mortality after acute myocardial infarction. , 2012, Journal of cardiology.

[27]  J. Maessen,et al.  The acute effect of intra-aortic balloon counterpulsation during extracorporeal life support: an experimental study. , 2007, Artificial organs.

[28]  B. Kiaii,et al.  Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. , 2004, The Annals of thoracic surgery.